$1.37
0.021.48%
At Close: -
$1.36
-0.01-0.73%
After Hours: 4:31 PM EDT
15 minutes delayed
Akebia Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Akebia Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $-0.04 | $-0.05 | 20.0 % |
Mar 2024 | 2024-05-09 | $-0.09 | $-0.08 | -12.5 % |
Dec 2023 | 2024-03-14 | $0 | $-0.04 | 100.0 % |
Sep 2023 | 2023-11-08 | $-0.08 | $-0.08 | 0.00 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $43.65M | $49.45M | -11.7 % |
Mar 2024 | 2024-05-09 | $32.61M | $46.34M | -29.6 % |
Dec 2023 | 2024-03-14 | $56.20M | $55.39M | 1.46 % |
Sep 2023 | 2023-11-08 | $42.05M | $48.18M | -12.7 % |
Akebia Therapeutics (AKBA) is scheduled to report earnings on November 6, 2024. The last reported earnings were for reported on August 8, 2024 for Q2.
The Actual EPS was $-0.04, which beat the estimate of $-0.05.
The Actual Revenue was $43.6M, which missed the estimate of $49.5M.
Browse earnings estimates, EPS, and revenue on all stocks.